Nova Labs CJC-1295 without DAC (2mg Peptide)
Long-Acting Growth Hormone Support, Recovery Enhancement & Anti-Aging Optimization
$40.00
CJC-1295 (without DAC) is a growth hormone-releasing hormone (GHRH) analogue investigated for its role in stimulating endogenous growth hormone release. Unlike the DAC-modified version, this form has a shorter half-life and is associated with more transient, pulsatile activity in experimental models.
It is studied for its interaction with growth hormone and insulin-like growth factor-1 (IGF-1) pathways in research settings.
Key Features:
2mg CJC-1295 (no DAC) per vial
GHRH analogue without DAC modification
Shorter half-life with more pulsatile activity profile
Investigated for stimulation of endogenous growth hormone release
Associated in research with modulation of IGF-1 pathways
Studied in relation to metabolic regulation and recovery-related processes
Suggested Use:
For research purposes only. Protocols vary depending on study design and should be determined by qualified professionals in an appropriate setting.
Storage:
Lyophilized form: Store in a cool, dry place (15–25°C), protected from light. Refrigeration (2–8°C) optional for extended storage
After reconstitution: Store at 2–8°C. Do not freeze. Use within a limited timeframe
Important Information:
This product is an investigational compound and is not approved for human or veterinary use. Intended strictly for laboratory research purposes. Not for use by individuals under 18, pregnant or breastfeeding individuals, or for any therapeutic application. Ensure compliance with applicable regulations.